Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
cancer
4
×
life sciences
national blog main
national top stories
new york blog main
4
×
san diego blog main
san diego top stories
san francisco blog main
startups
4
×
venture capital
4
×
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
ipo
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biogen
boston top stories
clinical trials
deerfield management
drug development
europe blog main
europe top stories
gilead sciences
What
bio
ipo
roundup
covid
drugs
fda
medicines
plans
acquisitions
activity
advance
ahead
announced
approvals
asco
biogen
biology
branded
ceo
choices
clamped
collabs
commissioner
company
consumers
costly
counterweight
cytokine
daniel
deal
delays
developing
economic
elevatebio
enhanced
fast
files
generic
gilead
gilead’s
Language
unset
Current search:
cancer
×
startups
×
" venture capital "
×
" new york blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs